RT @Science_Open: ‘Investigation of #antitumor activities of #trastuzumab delivered by #PLGA #nanoparticles’: an #openaccess article on #Sc…
‘Investigation of #antitumor activities of #trastuzumab delivered by #PLGA #nanoparticles’: an #openaccess article on #ScienceOpen - The aim of the work was to overcome the current limitations in the #clinical use of #therapeutic #antibodies - https://t.co
Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN https://t.co/tZQafr8Aa3
RT @NanobiolabBtbs: Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN @DovePress https://t.co/2qEmQvzBtw
RT @NanobiolabBtbs: Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN @DovePress https://t.co/2qEmQvzBtw
RT @NanobiolabBtbs: Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN @DovePress https://t.co/2qEmQvzBtw
RT @NanobiolabBtbs: Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN @DovePress https://t.co/2qEmQvzBtw
RT @NanobiolabBtbs: Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN @DovePress https://t.co/2qEmQvzBtw
RT @NanobiolabBtbs: Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN @DovePress https://t.co/2qEmQvzBtw
RT @NanobiolabBtbs: Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN @DovePress https://t.co/2qEmQvzBtw
Investigation of antitumor activities of trastuzumab delivered by PLGA | IJN @DovePress https://t.co/2qEmQvzBtw